索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 研究圣经
  • 中国知网(CNKI)
  • 西马戈
  • 乌尔里希的期刊目录
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 米亚尔
  • 科学索引服务 (SIS)
  • 欧洲酒吧
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Synthesis of Bioactive Chemicals Cross-linked Sodium Tripolyphosphate (TPP) - Chitosan Nanoparticles for Enhanced Cytotoxic Activity against Human Ovarian Cancer cell Line (PA-1)

Sujima Anbu A, Sahi SV and Venkatachalam P

Currently, nanotechnology makes an impact in all spheres of human life and creates increasing excitement especially in the field of biomedicine and bionanotechnology. The important symbiosis between nanotechnology and green chemistry is the use of bioactive chemicals for the synthesis of nanoparticles. The present research was focused on fabrication of biomolecules loaded chitosan nanoparticles using Gymnema sylvestre leaf extract (GSCNPs). The experiment was performed using ionic gelation technique and was characterized using FTIR, TEM, XRD, Zeta potential and pdi. The morphological investigation showed the presence of smooth spherical surfaced GSCNPs with 58-80 nm in size. The XRD results indicated the crystalline nature of the synthesized nanoparticles. The FTIR results showed the absorption peaks stretching from higher wavelength region to lower region demonstrating the interaction of tripolyphosphate with chitosan and biomolecules. The zeta potential revealed the positive surface charges proving the stability of the synthesized nanoparticles and homogeneous dispersion was presented by the polydispersity index. The cytotoxic activity was performed against PA-1 cell line and the IC50 values obtained were 931 µg/ml for G. sylvestre leaf extract (GSLE) and 378.4 µg/ml for GSCNPs respectively. The present study strongly suggested that the fabricated phytochemicals cross-linked chitosan nanoparticles from Gymnema sylvestre leaf extracts exhibited enhanced cytotoxic activity and it could be effectively used as a promising anticancer agent in the near future.